Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 253

1.

Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, incidence and potential risk factors: a single institution experience.

Volpi L, Sozzi G, Capozzi VA, Ricco' M, Merisio C, Di Serio M, Chiantera V, Berretta R.

Int J Gynecol Cancer. 2019 Feb;29(2):312-319. doi: 10.1136/ijgc-2018-000084. Epub 2019 Jan 18.

PMID:
30718312
2.

Tumor Extracellular Matrix Remodeling: New Perspectives as a Circulating Tool in the Diagnosis and Prognosis of Solid Tumors.

Giussani M, Triulzi T, Sozzi G, Tagliabue E.

Cells. 2019 Jan 23;8(2). pii: E81. doi: 10.3390/cells8020081. Review.

3.

Long term complications following pelvic and para-aortic lymphadenectomy for endometrial cancer, and incidence and potential risk factors: a single institution experience.

Volpi L, Sozzi G, Capozzi VA, Ricco' M, Merisio C, Serio MD, Chiantera V, Berretta R.

Int J Gynecol Cancer. 2019 Jan 18. pii: ijgc-2018-000084. doi: 10.1136/ijgc-2018-000084. [Epub ahead of print]

PMID:
30659029
4.

Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study.

Boeri M, Milione M, Proto C, Signorelli D, Russo GL, Galeone C, Verri C, Mensah M, Centonze G, Martinetti A, Sottotetti E, Pastorino U, Garassino MC, Sozzi G.

Clin Cancer Res. 2019 Jan 7. doi: 10.1158/1078-0432.CCR-18-1981. [Epub ahead of print]

PMID:
30617131
5.

Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial.

Vernieri C, Signorelli D, Galli G, Ganzinelli M, Moro M, Fabbri A, Tamborini E, Marabese M, Caiola E, Broggini M, Hollander L, Gallucci R, Vandoni G, Gavazzi C, Triulzi T, Colombo MP, Rizzo AM, Corsetto PA, Pruneri G, de Braud F, Sozzi G, Torri V, Garassino MC.

Clin Lung Cancer. 2018 Dec 19. pii: S1525-7304(18)30335-8. doi: 10.1016/j.cllc.2018.12.011. [Epub ahead of print]

PMID:
30617039
6.

Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy.

Pastorino U, Morelli D, Leuzzi G, Rolli L, Suatoni P, Taverna F, Bertocchi E, Boeri M, Sozzi G, Cantarutti A, Corrao G, Gronchi A.

Ann Surg Oncol. 2019 Mar;26(3):869-875. doi: 10.1245/s10434-018-07116-7. Epub 2019 Jan 3.

PMID:
30607764
7.

Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges.

Seijo LM, Peled N, Ajona D, Boeri M, Field JK, Sozzi G, Pio R, Zulueta JJ, Spira A, Massion PP, Mazzone PJ, Montuenga LM.

J Thorac Oncol. 2018 Dec 4. pii: S1556-0864(18)33501-9. doi: 10.1016/j.jtho.2018.11.023. [Epub ahead of print] Review.

PMID:
30529598
8.

Voids and compositional inhomogeneities in Cu(In,Ga)Se2 thin films: evolution during growth and impact on solar cell performance.

Avancini E, Keller D, Carron R, Arroyo-Rojas Dasilva Y, Erni R, Priebe A, Di Napoli S, Carrisi M, Sozzi G, Menozzi R, Fu F, Buecheler S, Tiwari AN.

Sci Technol Adv Mater. 2018 Nov 19;19(1):871-882. doi: 10.1080/14686996.2018.1536679. eCollection 2018.

9.

Circulating mir-320a promotes immunosuppressive macrophages M2 phenotype associated with lung cancer risk.

Fortunato O, Borzi C, Milione M, Centonze G, Conte D, Boeri M, Verri C, Moro M, Facchinetti F, Andriani F, Roz L, Caleca L, Huber V, Cova A, Camisaschi C, Castelli C, Cancila V, Tripodo C, Pastorino U, Sozzi G.

Int J Cancer. 2018 Nov 13. doi: 10.1002/ijc.31988. [Epub ahead of print]

PMID:
30426475
10.

p53 mutants cooperate with HIF-1 in transcriptional regulation of extracellular matrix components to promote tumor progression.

Amelio I, Mancini M, Petrova V, Cairns RA, Vikhreva P, Nicolai S, Marini A, Antonov AA, Le Quesne J, Baena Acevedo JD, Dudek K, Sozzi G, Pastorino U, Knight RA, Mak TW, Melino G.

Proc Natl Acad Sci U S A. 2018 Nov 13;115(46):E10869-E10878. doi: 10.1073/pnas.1808314115. Epub 2018 Oct 31.

11.

Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancer.

Andriani F, Landoni E, Mensah M, Facchinetti F, Miceli R, Tagliabue E, Giussani M, Callari M, De Cecco L, Colombo MP, Roz L, Pastorino U, Sozzi G.

BMC Cancer. 2018 Sep 18;18(1):899. doi: 10.1186/s12885-018-4772-0.

12.

Antibody-Fc/FcR Interaction on Macrophages as a Mechanism for Hyperprogressive Disease in Non-small Cell Lung Cancer Subsequent to PD-1/PD-L1 Blockade.

Lo Russo G, Moro M, Sommariva M, Cancila V, Boeri M, Centonze G, Ferro S, Ganzinelli M, Gasparini P, Huber V, Milione M, Porcu L, Proto C, Pruneri G, Signorelli D, Sangaletti S, Sfondrini L, Storti C, Tassi E, Bardelli A, Marsoni S, Torri V, Tripodo C, Colombo MP, Anichini A, Rivoltini L, Balsari A, Sozzi G, Garassino MC.

Clin Cancer Res. 2019 Feb 1;25(3):989-999. doi: 10.1158/1078-0432.CCR-18-1390. Epub 2018 Sep 11.

PMID:
30206165
13.

Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC.

Moro M, Caiola E, Ganzinelli M, Zulato E, Rulli E, Marabese M, Centonze G, Busico A, Pastorino U, de Braud FG, Vernieri C, Simbolo M, Bria E, Scarpa A, Indraccolo S, Broggini M, Sozzi G, Garassino MC.

J Thorac Oncol. 2018 Nov;13(11):1692-1704. doi: 10.1016/j.jtho.2018.07.102. Epub 2018 Aug 24.

14.

The PDGFRβ/ERK1/2 pathway regulates CDCP1 expression in triple-negative breast cancer.

Forte L, Turdo F, Ghirelli C, Aiello P, Casalini P, Iorio MV, D'Ippolito E, Gasparini P, Agresti R, Belmonte B, Sozzi G, Sfondrini L, Tagliabue E, Campiglio M, Bianchi F.

BMC Cancer. 2018 May 23;18(1):586. doi: 10.1186/s12885-018-4500-9.

15.

MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner.

Andriani F, Majorini MT, Mano M, Landoni E, Miceli R, Facchinetti F, Mensah M, Fontanella E, Dugo M, Giacca M, Pastorino U, Sozzi G, Delia D, Roz L, Lecis D.

J Hematol Oncol. 2018 Mar 20;11(1):45. doi: 10.1186/s13045-018-0594-4.

16.

RET fusions in a small subset of advanced colorectal cancers at risk of being neglected.

Pietrantonio F, Di Nicolantonio F, Schrock AB, Lee J, Morano F, Fuca G, Nikolinakos P, Drilon A, Hechtman JF, Christiansen J, Gowen K, Frampton GM, Gasparini P, Rossini D, Gigliotti C, Kim ST, Prisciandaro M, Hodgson J, Zaniboni A, Chiu VK, Milione M, Patel R, Miller V, Bardelli A, Novara L, Wang L, Pupa SM, Sozzi G, Ross J, Di Bartolomeo M, Bertotti A, Ali S, Trusolino L, Falcone A, de Braud F, Cremolini C.

Ann Oncol. 2018 Jun 1;29(6):1394-1401. doi: 10.1093/annonc/mdy090.

PMID:
29538669
17.

Laparoscopic Neuronavigation for Deep Lateral Pelvic Endometriosis: Clinical and Surgical Implications.

Chiantera V, Petrillo M, Abesadze E, Sozzi G, Dessole M, Catello Di Donna M, Scambia G, Sehouli J, Mechsner S.

J Minim Invasive Gynecol. 2018 Nov - Dec;25(7):1217-1223. doi: 10.1016/j.jmig.2018.02.015. Epub 2018 Mar 2.

PMID:
29501810
18.

Tumor Size, an Additional Risk Factor of Local Recurrence in Low-Risk Endometrial Cancer: A Large Multicentric Retrospective Study.

Sozzi G, Uccella S, Berretta R, Petrillo M, Fanfani F, Monterossi G, Ghizzoni V, Frusca T, Ghezzi F, Chiantera V, Scambia G.

Int J Gynecol Cancer. 2018 May;28(4):684-691. doi: 10.1097/IGC.0000000000001223.

PMID:
29489475
19.

Author Correction: Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2018 Feb 27;8(1):3965. doi: 10.1038/s41598-018-21279-z.

20.

Complement C4d-specific antibodies for the diagnosis of lung cancer.

Ajona D, Okrój M, Pajares MJ, Agorreta J, Lozano MD, Zulueta JJ, Verri C, Roz L, Sozzi G, Pastorino U, Massion PP, Montuenga LM, Blom AM, Pio R.

Oncotarget. 2017 Dec 26;9(5):6346-6355. doi: 10.18632/oncotarget.23690. eCollection 2018 Jan 19.

21.

Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer.

Berretta R, Capozzi VA, Sozzi G, Volpi L, Ceni V, Melpignano M, Giordano G, Marchesi F, Monica M, Di Serio M, Riccò M, Ceccaroni M.

Arch Gynecol Obstet. 2018 Apr;297(4):997-1004. doi: 10.1007/s00404-018-4675-y. Epub 2018 Jan 27.

PMID:
29380107
22.

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening.

Mensah M, Borzi C, Verri C, Suatoni P, Conte D, Pastorino U, Orazio F, Sozzi G, Boeri M.

J Vis Exp. 2017 Oct 26;(128). doi: 10.3791/56326.

23.

Establishment of patient derived xenografts as functional testing of lung cancer aggressiveness.

Moro M, Bertolini G, Caserini R, Borzi C, Boeri M, Fabbri A, Leone G, Gasparini P, Galeone C, Pelosi G, Roz L, Sozzi G, Pastorino U.

Sci Rep. 2017 Jul 27;7(1):6689. doi: 10.1038/s41598-017-06912-7. Erratum in: Sci Rep. 2018 Feb 27;8(1):3965.

24.

Self-Reported Long-Term Autonomic Function After Laparoscopic Total Mesometrial Resection for Early-Stage Cervical Cancer: A Multicentric Study.

Lucidi A, Windemut S, Petrillo M, Dessole M, Sozzi G, Vercellino GF, Baessler K, Vizzielli G, Sehouli J, Scambia G, Chiantera V.

Int J Gynecol Cancer. 2017 Sep;27(7):1501-1507. doi: 10.1097/IGC.0000000000001045.

PMID:
28708791
25.

Baseline and postoperative C-reactive protein levels predict mortality in operable lung cancer.

Pastorino U, Morelli D, Leuzzi G, Gisabella M, Suatoni P, Taverna F, Bertocchi E, Boeri M, Sozzi G, Cantarutti A, Corrao G.

Eur J Cancer. 2017 Jul;79:90-97. doi: 10.1016/j.ejca.2017.03.020. Epub 2017 May 1.

26.

Detection of microRNAs Using Chip-Based QuantStudio 3D Digital PCR.

Borzi C, Calzolari L, Conte D, Sozzi G, Fortunato O.

Methods Mol Biol. 2017;1580:239-247. doi: 10.1007/978-1-4939-6866-4_16.

PMID:
28439837
27.

Inflammatory status and lung function predict mortality in lung cancer screening participants.

Pastorino U, Morelli D, Marchianò A, Sestini S, Suatoni P, Taverna F, Boeri M, Sozzi G, Cantarutti A, Corrao G.

Eur J Cancer Prev. 2018 Jul;27(4):289-295. doi: 10.1097/CEJ.0000000000000342.

28.

Genomic Profiling of Patient-Derived Xenografts for Lung Cancer Identifies B2M Inactivation Impairing Immunorecognition.

Pereira C, Gimenez-Xavier P, Pros E, Pajares MJ, Moro M, Gomez A, Navarro A, Condom E, Moran S, Gomez-Lopez G, Graña O, Rubio-Camarillo M, Martinez-Martí A, Yokota J, Carretero J, Galbis JM, Nadal E, Pisano D, Sozzi G, Felip E, Montuenga LM, Roz L, Villanueva A, Sanchez-Cespedes M.

Clin Cancer Res. 2017 Jun 15;23(12):3203-3213. doi: 10.1158/1078-0432.CCR-16-1946. Epub 2017 Mar 16.

29.

Mutational Profile from Targeted NGS Predicts Survival in LDCT Screening-Detected Lung Cancers.

Verri C, Borzi C, Holscher T, Dugo M, Devecchi A, Drake K, Sestini S, Suatoni P, Romeo E, Sozzi G, Pastorino U, Boeri M.

J Thorac Oncol. 2017 Jun;12(6):922-931. doi: 10.1016/j.jtho.2017.03.001. Epub 2017 Mar 14.

30.

mir-660-p53-mir-486 Network: A New Key Regulatory Pathway in Lung Tumorigenesis.

Borzi C, Calzolari L, Centonze G, Milione M, Sozzi G, Fortunato O.

Int J Mol Sci. 2017 Jan 23;18(1). pii: E222. doi: 10.3390/ijms18010222.

31.

LKB1 Expression Correlates with Increased Survival in Patients with Advanced Non-Small Cell Lung Cancer Treated with Chemotherapy and Bevacizumab.

Bonanno L, De Paoli A, Zulato E, Esposito G, Calabrese F, Favaretto A, Santo A, Conte AD, Chilosi M, Oniga F, Sozzi G, Moro M, Ciccarese F, Nardo G, Bertorelle R, Candiotto C, De Salvo GL, Amadori A, Conte P, Indraccolo S.

Clin Cancer Res. 2017 Jul 1;23(13):3316-3324. doi: 10.1158/1078-0432.CCR-16-2410. Epub 2017 Jan 24.

32.

Alzheimer neuropathology without frontotemporal lobar degeneration hallmarks (TAR DNA-binding protein 43 inclusions) in missense progranulin mutation Cys139Arg.

Redaelli V, Rossi G, Maderna E, Kovacs GG, Piccoli E, Caroppo P, Cacciatore F, Spinello S, Grisoli M, Sozzi G, Salmaggi A, Tagliavini F, Giaccone G.

Brain Pathol. 2018 Jan;28(1):72-76. doi: 10.1111/bpa.12480. Epub 2017 Feb 15.

PMID:
27997711
33.

Early Effector T Lymphocytes Coexpress Multiple Inhibitory Receptors in Primary Non-Small Cell Lung Cancer.

Tassi E, Grazia G, Vegetti C, Bersani I, Bertolini G, Molla A, Baldassari P, Andriani F, Roz L, Sozzi G, Pastorino U, Mortarini R, Anichini A.

Cancer Res. 2017 Feb 15;77(4):851-861. doi: 10.1158/0008-5472.CAN-16-1387. Epub 2016 Dec 15.

34.

Metabolic Evaluation of Non-Small Cell Lung Cancer Patient-Derived Xenograft Models Using 18F-FDG PET: A Potential Tool for Early Therapy Response.

Valtorta S, Moro M, Prisinzano G, Bertolini G, Tortoreto M, Raccagni I, Pastorino U, Roz L, Sozzi G, Moresco RM.

J Nucl Med. 2017 Jan;58(1):42-47. doi: 10.2967/jnumed.116.176404. Epub 2016 Oct 20.

35.

CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.

Turdo F, Bianchi F, Gasparini P, Sandri M, Sasso M, De Cecco L, Forte L, Casalini P, Aiello P, Sfondrini L, Agresti R, Carcangiu ML, Plantamura I, Sozzi G, Tagliabue E, Campiglio M.

Oncotarget. 2016 Oct 25;7(43):69649-69665. doi: 10.18632/oncotarget.11935.

36.

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature.

Fortunato O, Verri C, Pastorino U, Sozzi G, Boeri M.

Microarrays (Basel). 2016 Jul 5;5(3). pii: E18. doi: 10.3390/microarrays5030018.

37.

Anaplastic lymphoma kinase aberrations correlate with metastatic features in pediatric rhabdomyosarcoma.

Gasparini P, Casanova M, Villa R, Collini P, Alaggio R, Zin A, Bonvini P, Antonescu CR, Boldrini R, Caserini R, Moro M, Centonze G, Meazza C, Massimino M, Bergamaschi L, Luksch R, Chiaravalli S, Bisogno G, Zaffaroni N, Daidone MG, Sozzi G, Ferrari A.

Oncotarget. 2016 Sep 13;7(37):58903-58914. doi: 10.18632/oncotarget.10368.

38.

Posterior pelvic exenteration and retrograde total hysterectomy in patients with locally advanced ovarian cancer: Clinical and functional outcome.

Berretta R, Marchesi F, Volpi L, Ricotta G, Monica M, Sozzi G, Di Serio M, Mautone D.

Taiwan J Obstet Gynecol. 2016 Jun;55(3):346-50. doi: 10.1016/j.tjog.2016.04.010.

39.

Lung cancer screening with low-dose spiral computed tomography: evidence from a pooled analysis of two Italian randomized trials.

Infante M, Sestini S, Galeone C, Marchianò A, Lutman FR, Angeli E, Calareso G, Pelosi G, Sozzi G, Silva M, Sverzellati N, Cavuto S, La Vecchia C, Santoro A, Alloisio M, Pastorino U.

Eur J Cancer Prev. 2017 Jul;26(4):324-329. doi: 10.1097/CEJ.0000000000000264.

PMID:
27222939
40.

Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes.

Morena D, Maestro N, Bersani F, Forni PE, Lingua MF, Foglizzo V, Šćepanović P, Miretti S, Morotti A, Shern JF, Khan J, Ala U, Provero P, Sala V, Crepaldi T, Gasparini P, Casanova M, Ferrari A, Sozzi G, Chiarle R, Ponzetto C, Taulli R.

Elife. 2016 Mar 17;5. pii: e12116. doi: 10.7554/eLife.12116.

41.

[Lung cancer screening in high-risk subjects: early detection with LDCT and risk stratification using miRNA-based blood test].

Sestini S, Boeri M, Marchianò A, Silva M, Calareso G, Galeone C, Sozzi G, Pastorino U.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 1):42-50. doi: 10.19191/EP16.1S1.P042.029. Italian.

42.

Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants.

Pastorino U, Boffi R, Marchianò A, Sestini S, Munarini E, Calareso G, Boeri M, Pelosi G, Sozzi G, Silva M, Sverzellati N, Galeone C, La Vecchia C, Ghirardi A, Corrao G.

J Thorac Oncol. 2016 May;11(5):693-699. doi: 10.1016/j.jtho.2016.02.011. Epub 2016 Feb 24.

43.

Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen.

Sverzellati N, Silva M, Calareso G, Galeone C, Marchianò A, Sestini S, Sozzi G, Pastorino U.

Eur Radiol. 2016 Nov;26(11):3821-3829. Epub 2016 Feb 11.

PMID:
26868497
44.

Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer.

Silva M, Galeone C, Sverzellati N, Marchianò A, Calareso G, Sestini S, La Vecchia C, Sozzi G, Pelosi G, Pastorino U.

J Thorac Oncol. 2016 Feb;11(2):187-93. doi: 10.1016/j.jtho.2015.10.014. Epub 2015 Dec 23.

45.

Synergistic Activation upon MET and ALK Coamplification Sustains Targeted Therapy in Sarcomatoid Carcinoma, a Deadly Subtype of Lung Cancer.

Pelosi G, Gasparini P, Conte D, Fabbri A, Perrone F, Tamborini E, Pupa SM, Ciravolo V, Caserini R, Rossi G, Cavazza A, Papotti M, Nakatani Y, Maisonneuve P, Pastorino U, Sozzi G.

J Thorac Oncol. 2016 May;11(5):718-728. doi: 10.1016/j.jtho.2016.01.009. Epub 2016 Jan 22.

46.

IL12RB2 Polymorphisms correlate with risk of lung adenocarcinoma.

Prigione I, Covone AE, Giacopelli F, Bocca P, Risso M, Tripodi G, Pistorio A, Sozzi G, Airoldi I, Ravazzolo R, Pistoia V.

Immunobiology. 2016 Feb;221(2):291-9. doi: 10.1016/j.imbio.2015.10.006. Epub 2015 Oct 29.

PMID:
26547104
47.

Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.

Andriani F, Bertolini G, Facchinetti F, Baldoli E, Moro M, Casalini P, Caserini R, Milione M, Leone G, Pelosi G, Pastorino U, Sozzi G, Roz L.

Mol Oncol. 2016 Feb;10(2):253-71. doi: 10.1016/j.molonc.2015.10.002. Epub 2015 Oct 22.

48.

Novel method to detect microRNAs using chip-based QuantStudio 3D digital PCR.

Conte D, Verri C, Borzi C, Suatoni P, Pastorino U, Sozzi G, Fortunato O.

BMC Genomics. 2015 Oct 23;16:849. doi: 10.1186/s12864-015-2097-9.

49.

Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.

Sestini S, Boeri M, Marchiano A, Pelosi G, Galeone C, Verri C, Suatoni P, Sverzellati N, La Vecchia C, Sozzi G, Pastorino U.

Oncotarget. 2015 Oct 20;6(32):32868-77. doi: 10.18632/oncotarget.5210.

50.

Gene Signatures Stratify Computed Tomography Screening Detected Lung Cancer in High-Risk Populations.

Hu J, Boeri M, Sozzi G, Liu D, Marchianò A, Roz L, Pelosi G, Gatter K, Pastorino U, Pezzella F.

EBioMedicine. 2015 Jul 8;2(8):831-40. doi: 10.1016/j.ebiom.2015.07.001. eCollection 2015 Aug.

Supplemental Content

Support Center